Revelation Biosciences Financial Overview
Revelation Biosciences's market cap is currently $5.08M. The company's EPS TTM is $-1.77; its P/E ratio is -0.03; Revelation Biosciences is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.
